We are creating a unified UKRI website that brings together the existing research council, Innovate UK and Research England websites.
If you would like to be involved in its development let us know.

UK and China researchers collaborate on global fight against superbugs


UK and China researchers collaborate on global fight against superbugs

A multimillion investment to address antimicrobial resistance (AMR) in China has been announced, with £8 million by the UK Research and Innovation (UKRI) AMR project through the Newton Fund, and 36 million RMB (£4.1m) from the National Natural Science Foundation of China (NSFC).

The funding will support new interdisciplinary China-UK AMR partnership hubs.

The four winning collaborations, with teams led by the University of Warwick and the Chinese Academy of Sciences; the University of Bristol and Peking University Health Science Centre; Cardiff University and China Agricultural University; and the University of Birmingham and Zhejiang University, bring together leading researchers from both countries to explore and address factors behind the rise in antibacterial resistance in China.

This interdisciplinary approach will enable researchers to:

  • investigate in detail the emergence and spread of resistant bacteria
  • understand the impact this has on the environment, agricultural systems, animals and humans using a 'one health' approach
  • develop new interventions, including new drugs
  • support policymakers to improve health and agricultural systems.

The new collaborations will build on the success of the 2016 China-UK AMR Partnership Initiative whose research provided supporting evidence for the Chinese government’s internationally recognised ban of colistin, an antibiotic of last resort, from animal use.

Dr Jonathan Pearce, Head of Infections and Immunity at the UKRI's Medical Research Council (MRC), said: “Resistance to antibiotics is a growing problem that does not respect national borders. We are facing an alarming rise in the number of bacteria becoming resistant to existing antibiotics without an increase in new antibiotics or new treatments.

“The upsurge in resistance is driven by a complex interplay of biomedical, animal, social, cultural and environmental factors and so an international and interdisciplinary approach like this is vital if we are to stop it in its tracks.”

Professor Fan Yingjie, Deputy Director-General of NSFC Bureau of International Cooperation, said: “NSFC has been building research links between China and UK for years and the launch of the four interdisciplinary research projects is a new evidence of the strong collaborative relationship between NSFC and UKRI. Combining the expertise and resources of both China and the UK has proven very successful in producing innovative and impactful results. I look forward to seeing the outcomes from today’s successful applicants.”

Further information

Read more on the MRC website

What is AMR?

Please sign up to our weekly newsletter to keep up to date: